Society guideline links: Pneumocystis pneumonia in patients without HIV

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Opportunistic infections in adults with HIV" and "Society guideline links: Invasive fungal infections".)

International

●Center for International Blood and Marrow Transplant Research (CIBMTR), National Marrow Donor Program (NMDP), European Blood and Marrow Transplant Group (EBMT), American Society for Blood and Marrow Transplant (ASBMT), Canadian Blood and Marrow Transplant Group (CBMTG), Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), Association of Medical Microbiology and Infectious Diseases (AMMI), the Center for Disease Control and Prevention (CDC), and the Health Resources and Services Administration (HRSA): Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients – A global perspective (RETIRED; published 2009)

United States

●American Academy of Pediatrics (AAP): Red Book – Pneumocystis jirovecii infections (2021)

●American Thoracic Society (AST): Guidelines on Pneumocystis jiroveci in solid organ transplantation (2019)

●ATS: An official statement on the treatment of fungal infections in adult pulmonary and critical care patients (2011)

Europe

●European Conference on Infections in Leukemia (ECIL): Guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients (2016)

●ECIL: Guidelines for treatment of Pneumocystis jirovecii pneumonia in non-HIV-infected haematology patients (2016)

●ECIL: Guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients (2016)

United Kingdom

●Children's Cancer and Leukaemia Group (CCLG): Guidelines for the prophylaxis of Pneumocystis Jirovecii Pneumonia (PJP) in children with solid tumours (2016)

Australia–New Zealand

●Royal Australasian College of Physicians (RACP): Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies (2014)